Amrinone

   
Google
 
Web NewDrugInformation.com

Amrinone


Drug - Amrinone
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Inamrinone Lactate
Multiple ingredients are in alphabetical order.

Strength - EQ 5MG BASE/ML
The potency of the active ingredient(s), Inamrinone Lactate. May repeat for multiple part products.

Applicant - BEDFORD
The firm name holding legal responsibility for Amrinone. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 075513
The FDA assigned number to Amrinone. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Amrinone. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 9, 2000
The date Amrinone was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Amrinone. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Amrinone is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bedford Laboratories Div Ben Venue Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Amrinone.

Amrinone